Home » Newsletters » BioWorld Science

BioWorld Science

May 5, 2021

View Archived Issues

Enrollment opens in phase IIa study of MK-1942 in treatment-resistant depression

Aprea begins enrollment in first-in-human study of APR-548 for TP53-mutated MDS

Prime, base editing are "finer scalpels" in dystrophy

APVO-442: a bispecific T-cell engager targeting PSMA and CD3 for treating prostate cancer

Proof of concept demonstrated with ABX-002 prodrug brain delivery of thyromimetic LL-340001

Zenshine compounds targeting E-NPP 1 have antitumor activity

Vaxart initiates enrollment in phase Ib boosting regimen trial of its norovirus vaccine

Revolo presents encouraging safety data for its peptide drug for allergic disease

Incyte discloses new CDK2/cyclin E inhibitors

BeiGene synthesizes STING modulators

BioCryst Pharmaceuticals presents complement factor D inhibitors

Cellectar Biosciences describes new phospholipid-drug conjugates for cancer

First healthy volunteers dosed in phase I/II study of HDT Bio's COVID-19 RNA vaccine in India

Fate Therapeutics patents new CARs for cancer immunotherapy

Betacellulin is a novel therapeutic target in schizophrenia

Positive topline data from GENESIS phase III study of motixafortide plus G-CSF in multiple myeloma

Kiniksa reports final data from first-in-human trial of KPL-404

New mutations in the SETX gene tied to ataxia with oculomotor apraxia type 2

Ascletis reports phase IIa data on ASC-22 for chronic hepatitis B

FDA clears IND for phase I/II study of Clarity's prostate cancer theranostic products

European Commission approves Sibnayal for distal renal tubular acidosis

Preclinical characterization of novel small molecule inhibitor of CD38, RBN-013209

SOM-3355 reduces chorea in patients with HD

Tecentriq approved in E.U. for first-line metastatic NSCLC with high PD-L1 expression

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Sex differences shape gene activity across the human brain
BioWorld
Genes that are switched on or off in the human brain differ between men and women. Moreover, these differences are not uniform. They vary across cortical regions...
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
Gilead Sciences patents new GTPase KRAS G12D inhibitors
BioWorld Science
Gilead Sciences Inc. has disclosed new GTPase KRAS G12D mutant inhibitors potentially useful for the treatment of cancer.